|
|
|
|
|
|
|
|
|
|
open access
Introduction
For a few years, a new generation
of so-called personal genome testing (PGT) companies has been marketing
genome-wide SNP analysis and whole genome sequencing directly to
consumers. These companies offer personal risks for dozens of diseases
simultaneously, including cardiovascular diseases, type 2 diabetes,
psychiatric conditions and many types of cancer. (Pathway: https://www.pathway.com; Knome: http://www.knome.com; Counsyl: https://www.counsyl.com; 23andme: http://www.23andme.com; deCODEme: http://www.decodeme.com)
Consumers can obtain this information through web-based services with (Pathway: https://www.pathway.com; Counsyl: https://www.counsyl.com) or without (23andme: http://www.23andme.com; deCODEme: http://www.decodeme.com)
the involvement of a medical professional in the signing off on the
test order. Consumers take a cheek swab sample at home, send their
sample to a molecular genetic testing laboratory through the mail and
receive their genetic test results on a secure personal webpage.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.